Diabetes News and Research

Latest Diabetes News and Research

Study finds high prevalence of type D personality among people with hypothyroidism

New research published in The Journal of Clinical Endocrinology & Metabolism finds a high prevalence of type D personality among people with hypothyroidism.

9 Apr 2024

Meat or not to meat? Study challenges health claims of plant-based substitutes

Study finds no significant cardiometabolic health benefits of plant-based meat analog diets compared to animal-based meat diets among Singaporeans at risk of type 2 diabetes, challenging assumptions about plant-based meat substitutes' health advantages.

9 Apr 2024

CMS121 holds promise for treating metabolic diseases

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 6, entitled, "CMS121: a novel approach to mitigate aging-related obesity and metabolic dysfunction."

9 Apr 2024

Study links glucose time series complexity to diabetes progression

Weiping Jia et al., at Shanghai Jiao Tong University School of Medicine Affiliated Sixth People's Hospital, China, conducted a study to explore the relationship between the complexity of glucose time series, as derived from continuous glucose monitoring (CGM), and the deterioration of glucose regulation.

9 Apr 2024

Childhood sedentariness associated with increase in blood insulin concentration, study shows

An increase in sedentary time from childhood is associated with a significant increase in blood insulin concentration, a new study shows.

9 Apr 2024

SGLT2 inhibitors: A game-changer in preventing heart failure and sudden cardiac deaths

study reveals that SGLT2 inhibitors consistently lower the risk of major adverse cardiovascular events by 9% across various patient groups, especially impacting cardiovascular death reduction, highlighting their broad therapeutic potential beyond diabetes management.

9 Apr 2024

Labels reveal the truth: "Ultra-processed" and "high in sugar" deter shoppers

Study highlights that labeling foods as "ultra-processed" can significantly influence US adults' perceptions of health risks and discourage purchase intentions, especially when labels also indicate high sugar content.

8 Apr 2024

Beta-blockers show no benefit for heart attack patients with normal heart function

The REDUCE-AMI trial found that long-term beta-blocker therapy does not reduce mortality risk in acute myocardial infarction patients with preserved left ventricular ejection fraction compared to no beta-blocker treatment.

8 Apr 2024

Treating early-stage heart failure in diabetic patients: Insights from ARISE-HF trial

One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes did not meet its primary endpoint, but a preplanned subgroup analysis found a statistically significant effect of treatment in patients who were not taking SGLT2 inhibitors or GLP-1 RAs, which are antidiabetic medications that also have benefits for the heart.

8 Apr 2024

Poor oral health linked to negative long-term systemic health outcomes

Those who report having poor oral health are as likely to have negative long-term systemic health outcomes as those previously diagnosed with periodontal disease, or gum disease, according to a new Tufts University School of Dental Medicine study published in The Journal of the American Dental Association.

8 Apr 2024

Edetate disodium-based chelation ineffective for heart attack patients with diabetes

People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-based chelation, a therapy that draws lead and other toxic metals linked to increased risk of heart disease and stroke out of the body, according to a study presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Lerodalcibep reduces LDL cholesterol by over 50% in high-risk patients

Among patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to standard cholesterol-lowering medication for one year reduced LDL, or "bad" cholesterol, levels by more than half on average, compared with a placebo.

8 Apr 2024

Novel cholesterol removal strategy shows potential benefits post-heart attack

The first trial of a novel strategy for removing cholesterol from patients' arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at the American College of Cardiology's Annual Scientific Session. However, the findings suggest that the strategy may be beneficial with longer follow-up.

8 Apr 2024

Study: Empagliflozin shows mixed results in heart attack patients

Use of the sodium glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin following a heart attack did not show a significant benefit in reducing overall heart failure hospitalizations or death from any cause, according to a study presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Healthy eating, physical activity, and medication: Type 2 diabetes patients' willingness to engage varies

The willingness to engage in various management options for T2D among recently diagnosed patients.

8 Apr 2024

Investigational drug plozasiran shows promise in reducing severe hypertriglyceridemia

In patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the investigational drug plozasiran reduced triglyceride levels by an average of 74% after 24 weeks of use without causing any significant safety concerns, according to research presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Ultra-processed foods linked to higher glaucoma risk, study warns

Study finds a significant relationship between the highest intake of ultra-processed foods, especially sweets, and an increased risk of developing glaucoma among Spanish university graduates, highlighting the importance of dietary quality for ocular health.

8 Apr 2024

Wound warriors: How microbes influence healing and infection risks

Study explores how wound microbiota affect skin repair and infection risk by altering host immune responses, underscoring the complexity of microbial interactions in wound healing.

7 Apr 2024

Burdock roots outshine dandelion in antidiabetic potential study

Study compares the antidiabetic potential of dandelion and burdock roots, finding burdock exhibits higher total phenolic content and α-amylase activity, while dandelion has higher total polysaccharide content, warranting further in vivo studies.

7 Apr 2024

Study shows promise of zilebesiran injection in reducing systolic blood pressure

A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to 12 mmHg on average at three months in patients whose blood pressure had remained uncontrolled despite compliance with their medication regimen, according to a study presented at the American College of Cardiology's Annual Scientific Session.

7 Apr 2024

Previous
1
...
61
62
63
64
65
66
67
...
1831
Next

Diabetes News and Research

Latest Diabetes News and Research

Study finds high prevalence of type D personality among people with hypothyroidism

Meat or not to meat? Study challenges health claims of plant-based substitutes

CMS121 holds promise for treating metabolic diseases

Study links glucose time series complexity to diabetes progression

Childhood sedentariness associated with increase in blood insulin concentration, study shows

SGLT2 inhibitors: A game-changer in preventing heart failure and sudden cardiac deaths

Labels reveal the truth: "Ultra-processed" and "high in sugar" deter shoppers

Beta-blockers show no benefit for heart attack patients with normal heart function

Treating early-stage heart failure in diabetic patients: Insights from ARISE-HF trial

Poor oral health linked to negative long-term systemic health outcomes

Edetate disodium-based chelation ineffective for heart attack patients with diabetes

Lerodalcibep reduces LDL cholesterol by over 50% in high-risk patients

Novel cholesterol removal strategy shows potential benefits post-heart attack

Study: Empagliflozin shows mixed results in heart attack patients

Healthy eating, physical activity, and medication: Type 2 diabetes patients' willingness to engage varies

Investigational drug plozasiran shows promise in reducing severe hypertriglyceridemia

Ultra-processed foods linked to higher glaucoma risk, study warns

Wound warriors: How microbes influence healing and infection risks

Burdock roots outshine dandelion in antidiabetic potential study

Study shows promise of zilebesiran injection in reducing systolic blood pressure

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Diabetes News and Research

Latest Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in